SaƱana, Geraldine A.
HRN: 21-64-61 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/24/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/24/2022
07/31/2022
IV
500mg
Q8H
UTI, AP
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractIntra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes